By PPN News Staff
Results from an initial laboratory study demonstrate that serum antibodies induced by the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) neutralize the SARS-CoV-2 omicron variant after three doses.
Sera obtained from vaccinees one month after receiving the booster vaccination, which would be the third dose of vaccine, neutralized omicron to levels that are comparable to those observed for the wild-type SARS-CoV-2 spike protein after two doses, according to the